| Literature DB >> 35116241 |
Lei Han1, Zhihong Yao1, Lin Xie2, Dongqi Li1, Cao Wang1, Yihao Yang1, Jifei Yang1, Zeyong Huang3, Kecheng Li1, Ya Zhang1, Lijuan Ye4, Zunxian Tan1, Yan Liu1, Qiuyun Chen1, Tiying Wang1, Zuozhang Yang1.
Abstract
BACKGROUND: The most ordinary subtype of lung cancer is lung adenocarcinoma (LuAC), which is characterized by strong metastatic ability. And LuAC rates in Xuanwei leads to the poor prognosis and high death rate. In this study, we systematically explored the molecular mechanism of LuAC bone metastasis in Xuanwei by transcriptome sequencing.Entities:
Keywords: RNA sequencing; Xuanwei lung adenocarcinoma (Xuanwei LuAC); bone metastasis; ceRNA; mRNA; ncRNAs
Year: 2021 PMID: 35116241 PMCID: PMC8799022 DOI: 10.21037/tcr-20-2376
Source DB: PubMed Journal: Transl Cancer Res ISSN: 2218-676X Impact factor: 1.241
Patient clinical information
| Index | P1 | P2 | P3 | M1 | M2 | M3 |
|---|---|---|---|---|---|---|
| Age, years | 50 | 73 | 64 | 43 | 74 | 65 |
| Gender | Male | Female | Female | Female | Male | Female |
| Site of metastasis | – | – | – | Bone | Bone | Bone |
Figure 1RNA-seq reveals distinct expression pattern of mRNAs, miRNAs, lncRNAs and circRNAs in primary lung adenocarcinoma patients and lung adenocarcinoma bone metastasis patients. (A,B,C,D) Unsupervised clustering analysis showing expression profiles of DEmRNAs, DEmiRNAs, DElncRNAs and DEcircRNAs in the patients with primary lung adenocarcinoma vs. lung adenocarcinoma bone metastasis.
Figure 2GO analysis of the DEmRNAs and DEncRNA between primary lung adenocarcinoma patients and lung adenocarcinoma bone metastasis patients. (A) GO analysis of DEmRNAs in the lung adenocarcinoma bone metastasis patients; (B) GO analysis of DEmiRNAs in the lung adenocarcinoma bone metastasis patients; (C) GO analysis for nearby protein-coding genes of DElncRNAs in the lung adenocarcinoma bone metastasis patients; (D) GO analysis of DEcircRNAs in the lung adenocarcinoma bone metastasis patients. Gene numbers in the GO term were presented in histography. The −log10 (P value) yields an enrichment score representing the significance of GO term enrichment among differentially expressed mRNAs and ncRNA.
Figure 3KEGG pathways for DEmRNAs and DEncRNA between primary lung adenocarcinoma patients and lung adenocarcinoma bone metastasis patients. (A) KEGG of DEmRNAs in the lung adenocarcinoma bone metastasis patients; (B) KEGG of DEmiRNAs in the lung adenocarcinoma bone metastasis patients; (C) KEGG of DElncRNAs in the lung adenocarcinoma bone metastasis patients; (D) KEGG of DEcircRNAs in the lung adenocarcinoma bone metastasis patients. Identification of linear transcripts in different biological pathways by KEGG pathway analysis. The −log10 (P value) produces an enrichment score indicating the importance of pathway correlation.
Figure 4The lung adenocarcinoma bone metastasis-related ceRNA network. (A) Regulatory network analysis of lncRNAs-miRNAs-mRNAs in lung adenocarcinoma bone metastasis patients. Global view of the ceRNA network. This network involves 27 DElncRNAs, 12 DEmiRNAs and 67 DEmRNAs. (B) Regulatory network analysis of circRNAs-miRNAs-mRNAs in lung adenocarcinoma bone metastasis patients. Global view of the ceRNA network. This network involves 40 DEcircRNAs, 17 DEmiRNAs and 71 DEmRNAs. Elliptic circular nodes represent mRNAs, rectangular nodes represent miRNAs, triangular nodes stand for lncRNAs and rhombus nodes stand for circRNAs. Red means up regulate, green means down regulate.
Figure 5qRT-PCR confirmed the ncRNAs and mRNA expression. qRT-PCR validate the expression level of key ncRNAs and mRNAs in Normal (N) (n=15) vs. lung adenocarcinoma patients (P) (n=15) vs. lung adenocarcinoma bone metastasis patients (M) (n=14). *, P<0.05; **, P<0.01; ***, P<0.001.